RevOpsis Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

RevOpsis Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop innovative treatments for chronic diseases, particularly in ophthalmology. The company's therapy aims at treating retinal diseases like age-related macular degeneration (AMD) by targeting angiogenic factors involved in disease progression using a plug-and-play system to accelerate the design and development of multispecific biologics, enabling doctors to improve the quality of life for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4109 Chandlerwood
  • Springfield, IL 62711
  • United States
+1 (646)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4109 Chandlerwood
  • Springfield, IL 62711
  • United States
+1 (646)

RevOpsis Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RevOpsis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 17-Sep-2025 Completed Generating Revenue
3. Grant 15-Oct-2024 Completed Pre-Clinical Trials
2. Later Stage VC 25-Apr-2024 $16.5M $16.6M Completed Pre-Clinical Trials
1. Later Stage VC 24-Aug-2022 $100K $100K Completed Pre-Clinical Trials
To view RevOpsis Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RevOpsis Therapeutics Patents

RevOpsis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260308242-A1 Compostions of multispecific antigen binding polypeptides and methods of use Pending 26-Mar-2025
WO-2026207091-A1 Compostions of multispecific antigen binding polypeptides and methods of use Pending 26-Mar-2025
AU-2024354938-A1 Compostions of multispecific antigen binding polypeptides and methods of use Pending 03-Oct-2023
EP-4788700-A1 Compostions of multispecific antigen binding polypeptides and methods of use Pending 03-Oct-2023
WO-2025076131-A1 Compostions of multispecific antigen binding polypeptides and methods of use Inactive 03-Oct-2023 C07K16/22
To view RevOpsis Therapeutics’s complete patent history, request access »

RevOpsis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RevOpsis Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ExSight Ventures Venture Capital Minority
National Institutes of Health Government
To view RevOpsis Therapeutics’s complete investors history, request access »

RevOpsis Therapeutics FAQs

  • When was RevOpsis Therapeutics founded?

    RevOpsis Therapeutics was founded in 2018.

  • Where is RevOpsis Therapeutics headquartered?

    RevOpsis Therapeutics is headquartered in Springfield, IL.

  • What is the size of RevOpsis Therapeutics?

    RevOpsis Therapeutics has 4 total employees.

  • What industry is RevOpsis Therapeutics in?

    RevOpsis Therapeutics’s primary industry is Drug Discovery.

  • Is RevOpsis Therapeutics a private or public company?

    RevOpsis Therapeutics is a Private company.

  • What is RevOpsis Therapeutics’s current revenue?

    The current revenue for RevOpsis Therapeutics is .

  • How much funding has RevOpsis Therapeutics raised over time?

    RevOpsis Therapeutics has raised $16.6M.

  • Who are RevOpsis Therapeutics’s investors?

    ExSight Ventures and National Institutes of Health have invested in RevOpsis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process